Literature DB >> 30429170

The term cognition-enhancing medications is misleading.

Joel R Lexchin1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30429170      PMCID： PMC6234949     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  5 in total

Review 1.  Memantine for dementia.

Authors:  R McShane; A Areosa Sastre; N Minakaran
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Optimizing medications in older adults with cognitive impairment: Considerations for primary care clinicians.

Authors:  Linda Lee; Tejal Patel; Frank Molnar; Dallas Seitz
Journal:  Can Fam Physician       Date:  2018-09       Impact factor: 3.275

3.  Drugs for Alzheimer's disease: best avoided. No therapeutic advantage.

Authors: 
Journal:  Prescrire Int       Date:  2012-06

Review 4.  Rivastigmine for Alzheimer's disease.

Authors:  Jacqueline S Birks; Lee Yee Chong; John Grimley Evans
Journal:  Cochrane Database Syst Rev       Date:  2015-09-22

5.  Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.

Authors:  Rosa Ahn; Alexandra Woodbridge; Ann Abraham; Susan Saba; Deborah Korenstein; Erin Madden; W John Boscardin; Salomeh Keyhani
Journal:  BMJ       Date:  2017-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.